Lymphoma, B-Cell Clinical Trials

A listing of Lymphoma, B-Cell medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 83 clinical trials
featured
TRANSCEND - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - TRANSCEND-CLL-004 - US  

(diffuse large B-cell lymphoma (DLBCL) NOS [de novo or transformed follicular lymphoma (tFL)], double/triple-hit lymphoma [DHL/THL], follicular lymphoma Grade 3B [FL3B], primary central nervous system

  • 1936 views
  • 03 Aug, 2021
  • 15 locations
Assess the Anti-Tumor Activity and Safety of Odronextamab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

) grade 1-3a *1,2 In patients with diffuse large B-cell lymphoma (DLBCL) *1,2 In patients with mantle cell lymphoma (MCL) that has relapsed after or is refractory to a BTK inhibitor

large b-cell lymphoma
mantle cell lymphoma
follicular lymphoma
measurable disease
renal function
  • 43 views
  • 02 Aug, 2021
  • 85 locations
Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)

lymphoma (cHL) diffuse large B-cell lymphoma (DLBCL) indolent non-Hodgkin lymphoma (iNHL) The study will have 2 phases: a safety lead-in and an efficacy expansion phase. The recommended

classical hodgkin lymphoma
large b-cell lymphoma
pembrolizumab
lymphoma
cancer
  • 45 views
  • 25 Jul, 2021
  • 25 locations
GEN3013 Trial in Patients With Relapsed Progressive or Refractory B-Cell Lymphoma

The trial is an open-label, multi-center safety trial of epcoritamab GEN3013 (DuoBody-CD3xCD20). The trial consists of two parts: a dose escalation part phase 1, first-in-human (FIH) and an expansion part phase 2a.

large b-cell lymphoma
rituximab
lymphoma
high grade b-cell lymphoma
mantle cell lymphoma
  • 316 views
  • 04 Aug, 2021
  • 100 locations
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma

This phase II study will evaluate whether a reduction in radiation dose and field size will maintain a high rate of local control while minimizing the risk of acute and late toxicity . Hypothesis: The radiation dose and treatment volume can be safely reduced from 30 Gy to 20 Gy …

neutrophil count
rituximab
high grade b-cell lymphoma
ct scan
chemoimmunotherapy
  • 8 views
  • 01 Aug, 2021
  • 13 locations
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 in patients with CLL/SLL and NHL who have failed or are intolerant to standard of care.

b-cell small lymphocytic lymphoma
blood transfusion
chronic lymphocytic leukemia refractory
rituximab
measurable disease
  • 92 views
  • 01 Aug, 2021
  • 102 locations
Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies

(PK) profile of MAK683 in patients with advanced malignancies such as Diffuse Large B cell Lymphoma (DLBCL), nasopharyngeal carcinoma (NPC) or other advanced solid tumors for whom no further effective

measurable disease
b-cell lymphoma
hodgkin's disease
cancer
  • 133 views
  • 02 Aug, 2021
  • 17 locations
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

Participants in this study will have diffuse large B-cell lymphoma (DLBCL) that has come back or not gotten better with treatment. The trial will study whether brentuximab vedotin plus two drugs

lenalidomide
b-cell lymphoma
rituximab
measurable disease
brentuximab
  • 0 views
  • 04 Aug, 2021
  • 75 locations
A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB Subtype DLBCL (ACE-LY-312)

) vs placebo plus R-CHOP in subjects 65 years of age with previously untreated non-germinal center diffuse large B-cell lymphoma.

  • 0 views
  • 03 Aug, 2021
  • 218 locations
A Phase 3 Trial of Epcoritamab in R/R DLBCL

, refractory diffuse large B-Cell Lymphoma

  • 0 views
  • 04 Aug, 2021
  • 84 locations